Search

Your search keyword '"Gopalan, Anuradha"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Gopalan, Anuradha" Remove constraint Author: "Gopalan, Anuradha" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
140 results on '"Gopalan, Anuradha"'

Search Results

1. The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1

3. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

6. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

10. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

11. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

12. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

14. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors

17. Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies

18. The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1

19. BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer

20. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

21. Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.

22. Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer

23. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations

24. ERG-driven prostate cancer emerges from basal-luminal hybrid cells

25. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer

26. Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

27. Data from Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

28. Supplementary Table S1 from Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

29. Supplementary Figure S3 from Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

30. Data from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer

31. Supplementary Methods and Data (posted 7/5/2011) from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer

32. Supplementary Methods, Figures, Tables, and References from Characterization of KRAS Rearrangements in Metastatic Prostate Cancer

33. Supplementary Table 1 from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

34. Data from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

35. Supplementary Figure Legend from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

36. Supplementary Figures from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

38. Supplementary Tables 1-2 from TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy

39. Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.

40. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer

41. Abstract B026: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

42. Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling

43. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists

46. Abstract 2200: Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling

47. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

48. Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies

49. sj-docx-1-ijs-10.1177_10668969221116629 - Supplemental material for Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists

50. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.

Catalog

Books, media, physical & digital resources